학술논문
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
Document Type
Artikel
Author
Source
Digestive diseases and sciences. 69(6):2175-2183
Subject
Language
English
English
English
ISSN
1573-2568